• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • EMBELIN
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ALLERGIES & CYTOKINES
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • AMPK
      • ANTI AGING
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • APOPTOSIS
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • BRASSINOSTEROIDS
      • CARDIAC GLYCOSIDES
      • CENTENARIANS
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DIABETES & CANCER
      • EPIGENETIC MODIFIERS
      • EXCITOXICITY & THE BRAIN
      • FGF21
      • FLAVONES
      • GLUTAMATE & BRAIN
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HMGB1
      • HORMESIS
      • HSP90 INHIBITORS
      • HYPERINSULINEMIA
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • IKK
      • IL-6/STAT3
      • IRISIN
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LIFESPAN EXTENSION
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MITOCHONDRIAL UNCOUPLING
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL AROMATASE INHIBITORS
      • NEUROINFLAMMATION
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR AND FEAR
      • NOOTROPICS
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SIRT1 & LONGEVITY
      • SUGAR & AGING
      • STAT3
      • TELOMERE SHORTENING & PREMATURE AGING
      • TRAUMATIC BRAIN INJURY (HEALING)
    • HOME
    • FAQ
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    INTERMITTENT FASTING
    February 12, 2021
    CARCININE
    February 19, 2021
    1. Metformin trims fats to restore insulin sensitivity
    2. The amelioration of hepatic steatosis by thyroid hormone receptor agonists is insufficient to restore insulin sensitivity in ob/ob mice
    3. Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C
    4. Normalization of insulin sensitivity with lithium in diabetic rats
    5. Improved insulin sensitivity in patients with type I diabetes mellitus after CSII
    6. D-chiro-inositol–its functional role in insulin action and its deficit in insulin resistance
    7. Exercise intensity, inflammatory signaling, and insulin resistance in obese rats.
    8. insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liver
    9. FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS
    10. Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes
    11. Phospholipid environment alters hormone-insulin sensitivity of the purified insulin receptor kinase
    12. Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep
    13. insulin resistance induced by tumor necrosis factor-α in myocytes and brown adipocytes
    14. n-3 Fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator–activated receptor-α–dependent manner
    15. Osteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-κB signaling …
    16. Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs
    17. Metabolic impact of puberty on the course of type 1 diabetes.
    18. Activating the longevity gene to restore insulin sensitivity and immune reciprocity in patients with metabolic syndrome
    19. Hyperglycemia-induced insulin resistance in diabetic dyslipidemic Yucatan swine
    20. Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats
    21. Co‐administration of glutathione and nitric oxide enhances insulin sensitivity in Wistar rats
    22. C1q/TNF-related protein-12 (CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetes
    23. Dehydroepiandrosterone decreases serum tumor necrosis factor-α and restores insulin sensitivity: independent effect from secondary weight reduction in genetically …
    24. Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways
    25. Liver-specific igf-1 gene deletion leads to muscle insulin ininsulin sensitivity
    26. Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance action
    27. Setting the stage: possible mechanisms by which acute contraction restores insulin sensitivity in muscle
    28. Early mitochondrial adaptations in skeletal muscle to diet-induced obesity are strain dependent and determine oxidative stress and energy expenditure but not insulin …
    29. Short‐term suppression of plasma free fatty acids fails to improve insulin sensitivity when intramyocellular lipid is elevated
    30. Treatment with an SSRI antidepressant restores hippocampo-hypothalamic corticosteroid feedback and reverses insulin resistance in low-birth-weight rats
    31. Linking mitochondrial bioenergetics to insulin resistance via redox biology
    32. The association between plasma adiponectin and insulin sensitivity in humans depends on obesity
    33. The effect of N-stearoylethanolamine on liver phospholipid composition of rats with insulin resistance caused by alimentary obesity
    34. Dual effects of resveratrol on arterial damage induced by insulin resistance in aged mice
    35. Skeletal muscle protein tyrosine phosphatase 1B regulates insulin sensitivity in African Americans
    36. Gliclazide protects 3T3L1 adipocytes against insulin resistance induced by hydrogen peroxide with restoration of GLUT4 translocation
    37. The effect of salicylates on insulin sensitivity
    38. Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway
    39. Curative diet supplementation with a melon superoxide dismutase reduces adipose tissue in obese hamsters by improving insulin sensitivity
    40. Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: A randomized double-blinded placebo-controlled …
    41. Targeting skeletal muscle mitochondria to prevent type 2 diabetes in youth
    42. The protein kinase IKKɛ regulates energy balance in obese mice
    43. Bioactives of Artemisia dracunculus L. enhance insulin sensitivity by modulation of ceramide metabolism in rat skeletal muscle cells
    44. Effect of Sutherlandia frutescens on the Lipid Metabolism in an insulin Resistant Rat Model and 3T3‐L1 Adipocytes
    45. Metabolic rescue of obese adipose-derived stem cells by Lin28/Let7 pathway
    46. Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individuals
    47. Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy.
    48. Modelling of detailed insulin receptor kinetics affects insulin sensitivity and noise in the downstream signalling pathway
    49. Leptin insulin sensitivity in skeletal muscle is modulated by diet and exercise
    50. Acute inactivity impairs glycemic control but not blood flow to glucose ingestion
    51. p53 Mediates impaired insulin signaling in 3T3‐L1 adipocytes during hyperinsulinemia
    52. Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM
    53. Targeting of PED/PEA-15 molecular interaction with phospholipase D1 enhances insulin sensitivity in skeletal muscle cells
    54. Chromium (III) propionate complex supplementation improves carbohydrate metabolism in insulin-resistance rat model
    55. Pathways leading to muscle insulin resistance–the muscle–fat connection
    56. Regulation of multicatalytic enzyme activity by insulin and the insulin-degrading enzyme
    57. Improvement of insulin sensitivity by a long-acting nifedipine preparation (nifedipine-CR) in patients with essential hypertension
    58. Pigment epithelium-derived factor contributes to insulin resistance in obesity
    59. insulin Resistance and β-Cell Dysfunction in Aging: The Importance of Dietary Carbohydrate
    60. Metabolic disruptions induced by reduced ambulatory activity in free-living humans
    61. Effect of duodenal–jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease
    62. Phosphatidylinositol 4, 5-Bisphosphate Reverses Endothelin-1–Induced insulin Resistance via an Actin-Dependent Mechanism
    63. Imidazoline-like drugs improve insulin sensitivity through peripheral stimulation of adiponectin and AMPK pathways in a rat model of glucose intolerance
    64. Increased 24h mean insulin-like growth factor binding protein-3 proteolytic activity in pubertal type 1 diabetic boys
    65. S 15261, a novel agent for the treatment of insulin resistance. Studies on Psammomys obesus. Effect on pancreatic islets of insulin resistant animals.
    66. Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition
    67. insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice
    68. Glyceollin improves endoplasmic reticulum stress-induced insulin resistance through CaMKK-AMPK pathway in L6 myotubes
    69. Inhibition of obesity-induced hepatic ER stress by early insulin therapy in obese diabetic rats
    70. Exploring off‐target binding of thiazolidinediones and a novel mechanism for restoring insulin sensitivity (854.2)
    71. Hyperinsulinemia induces insulin resistance on glucose and lipid metabolism in a human adipocytic cell line: paracrine interaction with myocytes
    72. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice
    73. Resveratrol is not as effective as physical exercise for improving reproductive and metabolic functions in rats with dihydrotestosterone-induced polycystic …
    74. Functional properties of Claramine: A novel PTP1B inhibitor and insulin-mimetic compound
    75. Niacin improves adiponectin secretion, glucose tolerance and insulin sensitivity in diet-induced obese rats
    76. insulin resistance and preeclampsia
    77. Modulation of PPARγ activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis
    78. Identification of influencing variables on adiponectin serum levels in diabetes mellitus type 1 and type 2
    79. Andrographolide attenuates tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes
    80. Exercise and insulin resistance
    81. Impact of PPAR-α induction on glucose homoeostasis in alcohol-fed mice
    82. Mitochondrial regulation of insulin action
    83. What can bariatric surgery teach us about the pathophysiology of type 2 diabetes?
    84. New series of aryloxypropanolamines with both human β3-adrenoceptor agonistic activity and free radical scavenging properties
    85. Glycolipid metabolism disorder in the liver of obese mice is improved by TUDCA via the restoration of defective hepatic autophagy
    86. Impaired insulin sensitivity and insulin secretion in Haemodialysis patients with and without Secondary Hyperparathyroidism
    87. insulin resistance, a new target for nitric oxide‐delivery drugs
    88. KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-α production
    89. Metabolic inflexibility in skeletal muscle: a prelude to the cardiometabolic syndrome?
    90. Effect of acute exercise or fasting on mitochondrial function and high fat diet-induced insulin resistance
    91. A family of Acrp30/adiponectin structural and functional paralogs
    92. The relationship between the hyperplastic pancreatic islet and insulin ininsulin sensitivity in obesity
    93. Resveratrol action in the duodenum and the regulation of insulin sensitivity
    94. Comparing the correlation of measures of insulin sensitivity in youth.
    95. Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance
    96. Obesity, immunomodulation and chronic kidney disease
    97. Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing …
    98. insulin-like action of vanadium compounds in fat cells
    99. Fenretinide Induces Ubiquitin‐Dependent Proteasomal Degradation of Stearoyl‐CoA Desaturase in Human Retinal Pigment Epithelial Cells
    100. Chronic treatment with growth hormone stimulates adiponectin gene expression in 3T3-L1 adipocytes
    101. The insulin-sensitizing role of the fat derived hormone adiponectin
    102. Abrogation of hyperosmotic impairment of insulin signaling by a novel class of 1, 2-dithiole-3-thiones through the inhibition of S6K1 activation
    103. The effect of manipulation of basal pulsatile insulin on insulin action in Type 2 diabetes
    104. insulin resistance and steatosis in hepatitis C virus infection
    105. The relationship between visfatin and HOMA-IR in hypertensive patients, and the effect of antihypertensive drugs on visfatin and HOMA-IR in hypertensive patients …
    106. Acute glucagon induces postprandial peripheral insulin resistance
    107. Skeletal muscle uncoupling protein‐3 restores upon intervention in the prediabetic and diabetic state: implications for diabetes pathogenesis?
    108. Interplay between FGF21 and insulin action in the liver regulates metabolism
    109. Fat accretion and the regulation of insulin-mediated glycogen synthesis after puberty in rats
    110. Fat cell insulin resistance: an experimental study focusing on molecular mechanisms in type 2 diabetes
    111. Therapeutic approaches to insulin resistance
    112. Endoplasmic reticulum stress does not mediate palmitate-induced insulin resistance in mouse and human muscle cells
    113. Low RIP140 expression partially restores metabolic flexibility in L6 muscle cells treated with high FA
    114. Proteomic and functional characterization of endogenous adiponectin purified from fetal bovine serum
    115. Poker face no more: cancer recurrence reveals its hand
    116. Disclosing the caffeine dose to be administered that restores insulin sensitivity in prediabetes animal
    117. Are oxidative stress− activated signaling pathways mediators of insulin resistance and β-cell dysfunction?
    118. Treatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant type 2 diabetic patients.(Key …
    119. Periodontal therapy: a useful adjunct to improve glycemic control
    120. In human adipocytes exposed to high glucose and insulin levels, IRS-1 displays altered phosphorylation and may be targeted for degradation
    121. Protective effect of aspirin in relation to IGF-1 in streptozotocin induced type-II diabetic rats
    122. Apocynin, an NADPH Oxidase Inhibitor, Prevents Hepatic and Peripheral insulin Resistance Induced by Short-Term Lipid Infusion
    123. The contrasting roles of PPARδ and PPARγ in regulating the metabolic switch between oxidation and storage of fats in white adipose tissue
    124. DiaMedica to Deliver Poster Presentation at World Conference on Clinical Pharmacology and Therapeutics
    125. Lipid disorders in diabetes mellitus and current management
    126. insulin sensitivity: measurements in the whole body and in isolated tissues
    127. Cation-induced restoration of insulin action in insulin-desensitized HTC cells
    128. Potential of surgery for curing type 2 diabetes mellitus
    129. Neutralization of tumor necrosis factor reverses age-induced impairment of insulin responsiveness in skeletal muscle of Sprague-Dawley rats
    130. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
    131. Diabetes: An Unfolding Story
    132. Obesity surgery may cure diabetes in nonobese patients
    133. Clinical management strategies for type 2 diabetes
    134. Combination therapy with acipimox enhances the effect of growth hormone treatment on linear body growth in the normal and small-for-gestational-age rat
    135. Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies
    136. LMO4 is Required for Central Leptin Control of Fat Metabolism and insulin sensitivity.
    137. insulin sensitizing effects of oligomannuronate-chromium (III) complexes in C2C12 skeletal muscle cells
    138. Angiotensin II receptor blocker ameliorates stress-induced adipose tissue inflammation and insulin resistance
    139. Anti-diabetic effects of benfotiamine on an animal model of type 2 diabetes mellitus
    140. Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle
    141. Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high-fat diet–fed mice
    142. Modulation of insulin resistance by PUFA in metabolic tissues
    143. SH2B1 Regulates insulin sensitivity and Glucose Homeostasis by Multiple Mechanisms.
    144. Hyperinsulin sensitivity to insulin during remissions in cyclosporin-treated IDDM patients
    145. Effect of antioxidant treatment on some indicators of obesity-induced changes in insulin sensitivity and beta-cell function in New Zealand white rabbits.
    146. Factors in serum from type 2 diabetes patients can cause cellular insulin resistance.
    147. Tadalafil ameliorates metabolic syndrome-induced alterations in visceral adipose tissue and liver: an experimental study in the rabbit
    148. Manipulation of the insulin-like growth factor 1 receptor on the vascular endothelium: the effect on whole body and endothelial specific insulin sensitivity
    149. Angiotensin II–induced insulin resistance is associated with enhanced insulin signaling
    150. EFFECT OF ASPIRIN PRETREATMENT IN STREPTOZOTOCINE INDUCED TYPE-II DIABETIC RATS
    151. Inflammatory cytokines, adiponectin, insulin resistance and metabolic control after periodontal intervention in patients with type 2 diabetes and chronic periodontitis
    152. Resveratrol improves insulin resistance of catch-up growth by increasing mitochondrial complexes and antioxidant function in skeletal muscle
    153. The FXR agonist obeticholic acid normalizes lipid droplet and triglyceride handling in visceral adipose tissue preadipocytes from a non-genomic rabbit model of …
    154. Sex differences in skeletal muscle Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) levels: A cross-sectional study
    155. N-3 Fatty Acids Preserve insulin sensitivity In Vivo in a PPARα-Dependent Manner
    156. Bone marrow stem cell transplant into intra-bone cavity prevents type 2 diabetes: role of heme oxygenase-adiponectin
    157. Dehydroepiandrosterone levels in Type 2 diabetes
    158. Effects of Exercise and Elevated Fatty Acid Availability on Muscle Lipid Metabolism and insulin sensitivity.
    159. insulin sensitivity and nutrient utilisation in skeletal muscle.
    160. Central Leptin, But Not Central insulin, Attenuates the Decrease of Adiponectin Concentrations and Increases insulin sensitivity in Streptozotocin (STZ)-Induced …
    161. Sirtuin 2 in hypothalamus: an emerging target in insulin resistance?
    162. Leucine-induced Impairment of insulin sensitivity in Skeletal Muscle of Healthy Rats is Reversible
    163. Reversible insulin sensitivity in Grizzly Bears (Ursus Arctos Horribilis): The Roles of Cell Autonomous and Exogenous Factors in Seasonal Glucose Metabolism
    164. N-stearoylethanolamine improves indicators of insulin resistance development under high-fat diet overload
    165. Heat shock proteins induction reduces stress kinases activation, potentially improving insulin signalling in monocytes from obese subjects
    166. Attenuation of Hepatic Leptin Signalling Leads to Improved Glucose Tolerance.
    167. Postprandial Free Fatty Acids (FFA) Metabolism Early in the Natural History of Type 2 Diabetes Mellitus (DM2)
    168. Ligand Binding Site AND Activity Correlations BY Hydrogen/Deuterium Exchange Mass Spectrometry
    169. Natural killer T cells
    170. DOES ASPIRIN PRETREATMENT PREVENT DIABETES IN RATS?
    171. Elevated NF-κB activation is conserved in human myocytes cultured from obese type 2 diabetic patients and attenuated by AMP-activated protein kinase
    172. Genetic evidence points to an osteocalcin‐independent influence of osteoblasts on energy metabolism
    173. Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic …
    174. Palmitate acutely induces insulin resistance in isolated muscle from obese but not lean humans
    175. Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans?
    176. Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice
    177. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo
    178. Diabetes: A fish story
    179. Identification of a new JNK inhibitor targeting the JNK-JIP interaction site
    180. Effects of insulin resistance on substrate utilization during exercise in overweight women
    181. The kidney: an unwilling accomplice in syndrome X
    182. Childhood obesity and insulin resistance in a Yucatan mini-piglet model: putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development
    183. Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation
    184. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis
    185. Phosphorylation of IRS Proteins: Yin‐Yang Regulation of insulin Signaling
    186. T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor γ binding properties
    187. Osteopontin in obesity-associated adipose tissue inflammation and insulin resistance and its interaction with monocyte chemoattractant protein-1
    188. c-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-α induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X …
    189. Generation, validation and humanisation of a novel insulin resistant cell model
    190. Effects of inhibition of the renin‐angiotensin system on the cardiovascular actions of insulin
    191. The role of adenosine in insulin action coupling in rat adipocytes
    192. The role of diet and nutrient composition in nonalcoholic fatty liver disease
    193. Ozone exposure triggers insulin resistance through muscle c-Jun N-terminal kinase activation
    194. Impact of periodontitis on the diabetes-related inflammatory status
    195. Tissue specificity on insulin action and resistance: past to recent mechanisms
    196. Ragaglitazar: the pharmacokinetics, pharmacodynamics, and tolerability of a novel dual PPARα and γ agonist in healthy subjects and patients with type 2 diabetes
    197. Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms
    198. Thiazolidinediones in type 2 diabetes mellitus
    199. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus
    200. Sterols and Terpenoids from Viburnum odoratissimum
    201. Antioxidants: do they have a role in the treatment of insulin resistance?
    202. Proteomic analysis of the palmitate-induced myotube secretome reveals involvement of the annexin A1-formyl peptide receptor 2 (FPR2) pathway in insulin …
    203. Chronic ethanol consumption ameliorates the maturity-onset diabetes-obesity syndrome in CBA mice
    204. Palmitate-activated macrophages confer insulin resistance to muscle cells by a mechanism involving protein kinase C θ and ε
    205. Deterioration of plasticity and metabolic homeostasis in the brain of the UCD-T2DM rat model of naturally occurring type-2 diabetes
    206. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet‐induced obese mice, independently of weight …
    207. An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice
    208. Fasting serum insulin and lipid levels in men with epilepsy
    209. Hyperthyroidism causes cardiac dysfunction by mitochondrial impairment and energy depletion
    210. The role of the lipogenic pathway in the development of hepatic steatosis
    211. Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance
    212. Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-α
    213. Defining the Importance of Fatty Acid Metabolism in Maintaining Adipocyte Function: A Dissertation
    214. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
    215. The role of s-nitrosothiols and rho-kinase 1 in glucose and lipid metabolism
    216. insulin resistance is a cellular antioxidant defense mechanism
    217. Turning off the inflammatory, but not the metabolic, flames
    218. Inhibitors of the lipid phosphatase SHIP2 discovered by high throughput affinity selection-mass spectrometry screening of combinatorial libraries
    219. Session 8: Mitochondria: from Biochemistry to Medicine Lectures Oral Presentations O8.
    220. Thujone, a component of medicinal herbs, rescues palmitate-induced insulin resistance in skeletal muscle
    221. Impact of alogliptin and pioglitazone on lipid metabolism in islets of prediabetic and diabetic Zucker Diabetic Fatty rats
    222. Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 …
    223. Reflections on inositol (s) for PCOS therapy: steps toward success
    224. Protein tyrosine phosphatases
    225. TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists
    226. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance
    227. Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply
    228. insulin resistance and response to antiviral therapy in chronic hepatitis C: mechanisms and management
    229. CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes
    230. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease
    231. Therapeutic roles of peroxisome proliferator–activated receptor agonists
    232. Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome.
    233. Differential regulation of dihydroceramide desaturase by palmitate versus monounsaturated fatty acids: implications for insulin resistance
    234. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia
    235. Conjugated linoleic acid may be useful in treating diabetes by controlling body fat and weight gain
    236. Brain signaling systems in the type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases
    237. Reciprocal interference between insulin and interferon‐alpha signaling in hepatic cells: A vicious circle of clinical significance?
    238. insulin restores myocardial presynaptic sympathetic neuronal integrity in insulin-resistant diabetic rats
    239. Adipokines mediate inflammation and insulin resistance
    240. Identification of tyrosine phosphatases that dephosphorylate the insulin receptor: a brute force approach based on “substrate-trapping” mutants
    241. Quercetin and quercetin‐3‐O‐glucuronide are equally effective in ameliorating endothelial insulin resistance through inhibition of reactive oxygen species …
    242. Optimization of cardiac metabolism in heart failure
    243. The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes
    244. Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM
    245. Comparison of peripheral metabolic effects of insulin and metformin following severe burn injury
    246. insulin secretion in hypothalamic obesity: Diurnal variation and the effect of naloxone
    247. Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling
    248. Rat amylin-(8—37) enhances insulin action and alters lipid metabolism in normal and insulin-resistant rats
    249. Dietary fat reduction and breast cancer outcome: results from the Women’s Intervention Nutrition Study (WINS)
    250. Poliphenolic-rich extracts from cocoa (Theobroma cacao L.) and cupuassu (Theobroma grandiflorum Willd. Ex Spreng. K. Shum) liquors: A comparison of metabolic …
    251. Differential effects of calorie restriction and exercise on the adipose transcriptome in diet-induced obese mice
    252. Squaric acids: a new motif for designing inhibitors of protein tyrosine phosphatases
    253. Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes
    254. Age-Appropriate Obesity Treatment
    255. FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival
    256. Gene and Cell Therapies for Diabetes Mellitus
    257. What we talk about when we talk about fat
    258. Chemerin induces insulin resistance in rat cardiomyocytes in part through the ERK1/2 signaling pathway
    259. The role of JNK proteins in metabolism
    260. insulin resistance in the offspring of parents with type 2 diabetes
    261. Adiponectin is required for PPARγ-mediated improvement of endothelial function in diabetic mice
    262. A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1‐year …
    263. Antioxidants in diabetic complications and insulin resistance
    264. Contribution of TNF-α to Obesity-Associated insulin Resistance
    265. Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity
    266. Aetiology of non-insulin dependent diabetes
    267. Contribution of salt intake to insulin resistance associated with hypertension
    268. NLRP3 at the interface of metabolism and inflammation
    269. The critical role of metabolic pathways in aging
    270. Endothelial dysfunction in (pre) diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes
    271. Regulation of Skeletal Muscle insulin Action by SIRT1 and STAT3
    272. The HSP co-inducer BGP-15 can prevent the metabolic side effects of the atypical antipsychotics
    273. Effective surgical treatment of diabetes for the obese patient
    274. Mechanism and management of AKT inhibitor-induced hyperglycemia
    275. Toll-like receptor 4-induced endoplasmic reticulum stress contributes to impairment of vasodilator action of insulin
    276. AMPK activators–potential therapeutics for metabolic and other diseases
    277. The role of insulin resistance in peripheral vascular disease
    278. Palmitate-induced inflammatory pathways in human adipose microvascular endothelial cells promote monocyte adhesion and impair insulin transcytosis
    279. Novel concepts in insulin regulation of hepatic gluconeogenesis
    280. Effect of high-fat diet on metabolic indices, cognition, and neuronal physiology in aging F344 rats
    281. When to use insulin in the maturity onset diabetic.
    282. Quantum medicine update
    283. Molecular targets related to inflammation and insulin resistance and potential interventions
    284. the treatment of non‐alcoholic steatohepatitis with thiazolidinediones
    285. Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes
    286. Histone deacetylase HDAC8 promotes insulin resistance and β-catenin activation in NAFLD-associated hepatocellular carcinoma
    287. The IGF-1 receptor and regulation of nitric oxide bioavailability and insulin signalling in the endothelium
    288. Novel in vivo studies on the effect of ethanolic stick cherries extract in diabetes management
    289. Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency: a randomized, controlled …
    290. Macrophage HIF-2α ameliorates adipose tissue inflammation and insulin resistance in obesity
    291. Leptin regulation of the immune response and the immunodeficiency of malnutrition1
    292. Antihyperglycemic effects of total flavonoids from Polygonatum odoratum in STZ and alloxan-induced diabetic rats
    293. Type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment
    294. The hypoglycemic effect of pumpkin seeds, Trigonelline (TRG), Nicotinic acid (NA), and D-Chiro-inositol (DCI) in controlling glycemic levels in diabetes mellitus
    295. Peroxisome proliferator-activated receptors and hepatitis C virus-induced insulin resistance
    296. Systematic review: Preventive and therapeutic applications of metformin in liver disease
    297. Chemokine expression in inflamed adipose tissue is mainly mediated by NF-κB
    298. Obesity, inflammation, and the potential application of pharmaconutrition
    299. Diabetes and gum disease: the diabolic duo
    300. Kinetics and molecular docking studies of pimarane-type diterpenes as protein tyrosine phosphatase (PTP1B) inhibitors from Aralia continentalis roots
    301. Restoring HSP70 deficiencies improves glucose tolerance in diabetic monkeys
    302. Eosinophils reduce chronic inflammation in adipose tissue by secreting Th2 cytokines and promoting M2 macrophages polarization
    303. Process Development on the Enantioselective Enzymatic Hydrolysis of S-Ethyl 2-Ethoxy-3-(4-hydroxyphenyl)propanoate
    304. The beta cell function in NIDDM patients with secondary failure
    305. Inflammatory mechanisms in obesity
    306. Periodontal treatment with topical antibiotics improves glycemic control in association with elevated serum adiponectin in patients with type 2 diabetes mellitus
    307. Tissue-specific regulation and expression of heat shock proteins in type 2 diabetic monkeys
    308. Lipotoxicity versus adipotoxicity—the deleterious effects of adipose tissue on beta cells in the pathogenesis of type 2 diabetes
    309. Glucose Uptake and Its Consequence on Cardiomyocyte Function
    310. n− 3 Fatty acids and the metabolic syndrome
    311. Mechanisms in endocrinology: Non-alcoholic fatty liver disease in common endocrine disorders
    312. New hope for type 2 diabetics: Targeting insulin resistance through the immune modulation of stem cells
    313. Therapeutic targets of brain insulin resistance in sporadic Alzheimer’s disease
    314. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects
    315. Troxerutin reverses fibrotic changes in the myocardium of high-fat high-fructose diet-fed mice
    316. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes
    317. Angiotensin-converting enzyme inhibition delays onset of glucosuria with regression of renal injuries in genetic rat model of non-insulin-dependent diabetes mellitus
    318. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with …
    319. Tissue availability of insulin-like growth factor I is inversely related to insulin resistance in essential hypertension: effects of angiotensin converting enzyme inhibition
    320. Targeting host factors: a novel rationale for the management of hepatitis C virus
    321. Use of mouse models in studying type 2 diabetes mellitus
    322. Cardiovascular prevention in type 2 diabetes mellitus patients: the role of oral glucose-lowering agents
    323. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer’s disease
    324. insulin relaxes bladder via PI3K/AKT/eNOS pathway activation in mucosa: unfolded protein response‐dependent insulin resistance as a cause of obesity‐associated …
    325. Overexpression of vesicle-associated membrane protein (VAMP) 3, but not VAMP2, protects glucose transporter (GLUT) 4 protein translocation in an in vitro …
    326. Drug-induced disorders of glucose tolerance
    327. Pharmacological activation of thyroid hormone receptors elicits a functional conversion of white to brown fat
    328. Drug-induced hyperglycaemia and diabetes
    329. Diabetes in mice with selective impairment of insulin action in Glut4-expressing tissues
    330. Palmitate-Activated Macrophages Confer insulin Resistance to Muscle Cells by a Mechanism Involving
    331. Blocking CD40-TRAF6 interactions by small-molecule inhibitor 6860766 ameliorates the complications of diet-induced obesity in mice
    332. Use of insulin sensitizers in NASH
    333. The angiotensin-melatonin axis
    334. Improving glucose metabolism with resveratrol in a swine model of metabolic syndrome through alteration of signaling pathways in the liver and skeletal muscle
    335. The emerging role of thiazolidinediones in the treatment of diabetes-mellitus and related disorders
    336. Sodium glucose co-transporter 2 (SGLT2) inhibitors as potential antidiabetic agents
    337. Development of leptin resistance in rat soleus muscle in response to high-fat diets
    338. Aging does not reduce heat shock protein 70 in the absence of chronic insulin resistance
    339. Metabolic syndrome in HD patients: association with body composition, nutritional status, inflammation and serum iron
    340. The Relationship Among Obesity, Inflammation, and insulin Resistance
    341. Phenylmethimazole blocks palmitate-mediated induction of inflammatory cytokine pathways in 3T3L1 adipocytes and RAW 264.7 macrophages
    342. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects
    343. Hypermethylation of hepatic glucokinase and L-type pyruvate kinase promoters in high-fat diet–induced obese rats
    344. How metabolism generates signals during innate immunity and inflammation
    345. Targeting PGC-1α to control energy homeostasis
    346. Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents
    347. The overexpression of carnitine palmitoyl transferase1 and its influence on the lipid metabolism of rat hepatocytes
    348. Cardiotrophin-1 is a key regulator of glucose and lipid metabolism
    349. Sulfonylureas in NIDDM
    350. Pharmacological properties of the central antihypertensive agent, moxonidine
    351. Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer’s disease
    352. Use of metformin in the treatment of polycystic ovary syndrome
    353. The multiple universes of estrogen-related receptor α and γ in metabolic control and related diseases
    354. The intersection of inflammation, insulin resistance and ageing: implications for the study of molecular signalling pathways in horses
    355. Reactive oxygen species play a causal role in multiple forms of insulin resistance
    356. Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes
    357. Effectiveness of telmisartan as an adjunct to metformin in treating type II diabetes mellitus in rats
    358. Female rats are relatively more sensitive to reduced lipid versus reduced carbohydrate availability
    359. The role of adiponectin in reproduction: from polycystic ovary syndrome to assisted reproduction
    360. My βIG Fat Math Model: β-Cell Compensation and Type 2 Diabetes
    361. Antihyperglycaemic properties of the ethyl acetate extract of Dennettia tripetala in diabetic rats
    362. Free fatty acid-induced insulin resistance in the obese is not prevented by rosiglitazone treatment
    363. Obesity and adipose tissue expansion in Ossabaw swine
    364. Biphasic effect of alcohol intake on the development of fatty liver disease
    365. insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon α‐2b plus ribavirin
    366. insulin-like growth factors and their binding proteins: biological actions
    367. Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?
    368. CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocyte cultures
    369. Constitutive expression of suppressor of cytokine signalling-3 in skeletal muscle leads to reduced mobility and overweight in mice
    370. Oral administration of immunoglobulin G‐enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells
    371. Bariatric surgery decreases monocyte-platelet aggregates in blood: a pilot study
    372. Nonalcoholic fatty liver disease: the potential role of nutritional management
    373. POSTERS: CLINICAL THERAPEUTICS/NEW TECHNOLOGY-TREATMENT OF insulin RESISTANCE
    374. A study of the biological activities of Avena sativa extracts
    375. Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes
    376. insulin-like growth factor-related proteins and diabetic complications
    377. Effect of lithium on plasma glucose, insulin and glucagon in normal and streptozotocin-diabetic rats: role of glucagon in the hyperglycaemic response.
    378. Novel “second-generation” approaches for the control of type 2 diabetes
    379. Reversal of obesity-induced hypertriglyceridemia by (R)-α-lipoic acid in ZDF (fa/fa) rats
    380. Anti-diabetic effects of polysaccharides from Opuntia monacantha cladode in normal and streptozotocin-induced diabetic rats
    381. MyD88 regulates physical inactivity-induced skeletal muscle inflammation, ceramide biosynthesis signaling, and glucose intolerance
    382. NPY signalling in early osteoblasts controls glucose homeostasis
    383. Pathophysiological Relevance of PPAR to Osteoarthritis: From the Control of Inflammation to Cartilage Protection?
    384. VEGF-B Blockade in muscle endothelium: a potential barrier to type 2 diabetes
    385. Nutritional and hormonal modulation of adiponectin and its receptors adipoR1 and adipoR2
    386. TNF-α and adipocyte biology
    387. Red Light Therapy for Diabetes and insulin Resistance
    388. George Q. Li,” Antony Kam,” Ka H. Wong,” Xian Zhou,’Eshaifol A. Omar,’Ali Alqahtani,” Kong M. Li,”
    389. Role of T cells in malnutrition and obesity
    390. Amino acids and mTORC1: from lysosomes to disease
    391. Pathogenesis of insulin resistance in metabolic obesity
    392. Anti-diabetic activity of Vaccinium bracteatum Thunb. leaves’ polysaccharide in STZ-induced diabetic mice
    393. 12-and 15-lipoxygenases in adipose tissue inflammation
    394. insulin Action at the Molecular Level: Facts and Speculations
    395. Adipocyte expression of PU. 1 transcription factor causes insulin resistance through upregulation of inflammatory cytokine gene expression and ROS production
    396. Tissue resident regulatory T cells: novel therapeutic targets for human disease
    397. Computational pharmacokinetics and in vitro-in vivo correlation of anti-diabetic synergistic phyto-composite blend
    398. Ozone exposure triggers insulin resistance through muscle c-Jun N-terminal Kinases (JNKs) activation
    399. Surgery in the treatment of type 2 diabetes mellitus
    400. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury
    401. Antihyperglycemic effects of the methanol leaf extract of Diaphananthe bidens in normoglycemic and streptozotocin–induced hyperglycemic rats
    402. Critical role of the Src homology 2 (SH2) domain of neuronal SH2B1 in the regulation of body weight and glucose homeostasis in mice
    403. The road less traveled: modulating signal transduction enzymes by inhibiting their protein–protein interactions
    404. Regulation of glucose transport and expression of GLUT3 transporters in human circulating mononuclear cells: studies in cells from insulin-dependent diabetic and …
    405. Trauma and hemorrhage-induced acute hepatic insulin resistance: Dominant role of tumor necrosis factor-α
    406. Mechanisms of disease: mitochondrial dysfunction in sensory neuropathy and other complications in diabetes
    407. Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease
    408. Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction
    409. p38 mitogen-activated protein kinase-dependent transactivation of ErbB receptor family: a novel common mechanism for stress-induced IRS-1 serine phosphorylation …
    410. Carnitine in metabolic disease: potential for pharmacological intervention
    411. Ipragliflozin and other sodium–glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: preclinical and clinical data
    412. Metabolic Control by Inflammation and Immunity: Toll-like receptor 4-induced endoplasmic reticulum stress contributes to impairment of vasodilator action of …
    413. Development of Personal UVB Sensor: Detection of Previtamin D Photosynthesis
    414. Implication of mitochondria endoplasmic-reticulum interactions in the control of hepatic metabolism
    415. Tsc2 is a molecular checkpoint controlling osteoblast development and glucose homeostasis
    416. Diosgenin, 4-hydroxyisoleucine, and fiber from fenugreek: mechanisms of actions and potential effects on metabolic syndrome
    417. Metformin modulates insulin post-receptor signaling transduction in chronically insulin-treated Heps G2 cells
    418. Effects of physical activity upon the liver
    419. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance
    420. A pharmacokinetic and pharmacodynamic study of pioglitazone in a model of induced insulin resistance in normal horses
    421. Effect of Vaccinium bracteatum Thunb. leaves extract on blood glucose and plasma lipid levels in streptozotocin-induced diabetic mice
    422. Effect of growth hormone on carbohydrate and lipid metabolism
    423. High speed development work by preparation of an “in‐hand” library of NMR‐quantified degradation products
    424. A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of …
    425. Adaptive reciprocity of lipid and glucose metabolism in human short-term starvation
    426. Review of the roles of conjugated linoleic acid in health and disease
    427. The pro‐inflammatory environment in recalcitrant diabetic foot wounds
    428. Enhanced fatty acid flux triggered by adiponectin overexpression
    429. Increases in free, unbound insulin-like growth factor I enhance insulin responsiveness in human hepatoma G2 cells in culture
    430. The role of IGF-I in the development of cardiovascular disease in type 2 diabetes mellitus: is prevention possible?
    431. Covalent peroxisome proliferator-activated receptor γ adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions
    432. insulin resistance and the modulation of rat cardiac K+ currents
    433. First Choice of Antihypertensive Therapy
    434. First Choice of Antihypertensive Therapy
    435. Moderate exercise restores pancreatic beta-cell function and autonomic nervous system activity in obese rats induced by high-fat diet
    436. Caffeine reduces TNFα up-regulation in human adipose tissue primary culture
    437. The hypoglycemic effect of Juglans regia leaves aqueous extract in diabetic patients: A first human trial
    438. Type 2 diabetes mellitus in chronic hepatitis C virus infection: risk factor or consequence?
    439. Genetic manipulation of Receptor Interacting Protein (RIP140) uncovers its critical role in the regulation of metabolism, gene expression and insulin signaling …
    440. Current and emerging treatment options in diabetes care
    441. Hypoglycaemic effects of fermented mycelium of Paecilomyces farinosus (G30801) on high-fat fed rats with streptozotocin-induced diabetes
    442. The pleiotropic functions of peroxisome proliferator-activated receptor γ
    443. Therapeutic use of recombinant methionyl human leptin
    444. Zinc transporters, mechanisms of action and therapeutic utility: implications for type 2 diabetes mellitus
    445. Mitochondrial pyruvate import and its effects on homeostasis
    446. Exercise pills: at the starting line
    447. Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2
    448. Diabetes mellitus and periodontal diseases
    449. New progress in adipocytokine research
    450. Metabolomic analyses for atherosclerosis, diabetes, and obesity
    451. Chronic prenatal ethanol exposure increases adiposity and disrupts pancreatic morphology in adult guinea pig offspring
    452. Type 2 diabetes–tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines
    453. Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 …
    454. Hormonal control of diabetes type 2 after surgery: Clinical and experimental evaluation
    455. Old drug acquires new target: metformin and Sirt1
    456. Effects of vanadate on glucose production in cultured hepatocytes isolated from rats on high saturated fat diet
    457. Getting rid of JNK
    458. Separation of insulin signaling into distinct GLUT4 translocation and activation steps
    459. Weight-reduction through a low-fat diet causes differential expression of circulating microRNAs in obese C57BL/6 mice
    460. A detailed study on poly cystic ovarian syndrome and it’s treatment with natural products
    461. Cardiometabolic interventions–focus on transcriptional regulators
    462. Angiotensin-Converting Enzyme Inhibition Delays Onset
    463. Regulation of glucose transporter messenger RNA levels in rat adipose tissue by insulin
    464. The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation
    465. Rescue of fructose-induced metabolic syndrome by antibiotics or faecal transplantation in a rat model of obesity
    466. Possibility of ozone depletion monitoring in conditions of opaque atmosphere using D-dosimeter
    467. Composition and hypoglycemic effect of camel milk in streptozotocin-induced diabetic rats
    468. Apparent induction of partial thymic regeneration in a normal human subject: a case report
    469. Therapeutic perspectives for type 2 diabetes mellitus: molecular and clinical insights
    470. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress
    471. Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives
    472. PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update
    473. 12/15-Lipoxygenase signaling in the endoplasmic reticulum stress response
    474. Antihyperglycemic effect of diosmin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats
    475. Concerted stimuli regulating osteo-chondral differentiation from stem cells: phenotype acquisition regulated by microRNAs
    476. Pancreatic ultrastructural enhancement due to telmisartan plus sitagliptin treatment in diet-induced obese C57BL/6 mice
    477. Protein kinase C: mediator or inhibitor of insulin action?
    478. The effect of 2-month bromocriptine treatment on the activity of the adenylyl cyclase signaling system in the myocardium and testes of rats with type 2 diabetes
    479. Oral hypoglycaemic agents.
    480. Kidney Failure Cause
    481. Diabetes mellitus and inflammatory periodontal diseases
    482. Genomics, nutrition, obesity, and diabetes
    483. Muscular response and adaptation to diabetes mellitus
    484. Tumor necrosis factor α (TNFα) stimulates Map4k4 expression through TNFα receptor 1 signaling to c-Jun and activating transcription factor 2
    485. Drug-induced diabetes mellitus
    486. Systems biology of adipose tissue metabolism: regulation of growth, signaling and inflammation
    487. Glucose control and integration by the skeleton
    488. Interrelationships between obesity and diabetes
    489. Plasma leptin levels after biliopancreatic diversion: dissociation with body mass index
    490. Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans
    491. The sirtuin family’s role in aging and age-associated pathologies
    492. Mechanism and Management of AKT Inhibitor-Induced Hyperglycemia
    493. Mediterranean Diet is an Effective Method for Treating Type 2 Diabetes in Adults
    494. Pathophysiological relevance of peroxisome proliferators activated receptors (PPAR) to joint diseases–the pro and con of agonists
    495. Protein tyrosine phosphatase 1B inhibitory activity of alkaloids from Rhizoma Coptidis and their molecular docking studies
    496. Metabolic complications associated with HIV protease inhibitor therapy
    497. Polycystic Ovarian Syndrome: a new perspective
    498. Peripheral and hepatic vein cytokine levels in correlation with non-alcoholic fatty liver disease (NAFLD)-related metabolic, histological, and haemodynamic …
    499. Design, synthesis, and structure− activity relationship of substrate competitive, selective, and in vivo active triazole and thiadiazole inhibitors of the c-Jun N-terminal …
    500. Pharmacogenetics of Diabetes
    501. Type 4 Hyperlipoproteinemia: One Theory of Atherogenesis
    502. Anti-inflammatory and antidiabetic roles of PPAR gamma
    503. Twelve weeks of pioglitazone therapy significantly attenuates dysmetabolism and reduces inflammation in continuous ambulatory peritoneal dialysis patients—a …
    504. The nuts and bolts of AGC protein kinases
    505. D‐CHIRO‐INOSITOL FOUND IN MOMORDICA CHARANTIA FRUIT EXTRACT PLAYS A ROLE IN REDUCING BLOOD GLUCOSE IN STREPTOZOTOCIN‐DIABETIC …
    506. insulin receptor substrate (IRS)‐1 regulates murine embryonic stem (mES) cells self‐renewal
    507. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic β-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein …
    508. Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane
    509. Rosiglitazone reverses increased duodenal inhibitory response in spontaneously hypertensive rats
    510. The Medicinal Plant Sutherlandia Frutescens Regulates Gene Expression to Reverse insulin Resistace in Rats
    511. Momordica charantia and type 2 diabetes: from in vitro to human studies
    512. Thesis, antithesis, and synthesis in periodontal and systemic interlink
    513. Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications
    514. Hepatitis C and steatosis
    515. Therapeutic potential of intravenously administered mesenchymal stem cells in diet-induced obesity
    516. Rhesus macaques develop metabolic syndrome with reversible vascular dysfunction responsive to pioglitazone
    517. The effect of scaling and root planing on glycaemic control, periodontal status and gingival crevicular fluid TNF-α levels in an Indian population-to reveal the …
    518. Cellular models for the analysis of signaling by protein kinase B and the forkhead transcription factor FKHR (Foxo1a)
    519. Secondary Diabetes: Drug Induced Diabetes
    520. Metal-based anti-diabetic drugs: advances and challenges
    521. Extrahepatic morbidity and mortality of chronic hepatitis C
    522. Chemokine Expression in Inflamed Adipose Tissue Is Mainly Mediated
    523. Histone deacetylase HDAC8 promotes insulin resistance and-catenin
    524. PPAR ligands for the treatment of insulin resistance
    525. P2-455: The neurocognitive effects of donepezil on visual short-term memory capacity following 24 Hours of sleep deprivation
    526. Polycystic ovarian syndrome: a new perspective
    527. Inhibition of Vascular Endothelial Growth Factor Signaling Stimulates Erythropoiesis and Sensitizes Hepatic insulin Signaling Through Activation of Hepatic …
    528. Periodontitis and diabetes—a complex relationship
    529. Taurine in health and diseases: consistent evidence from experimental and epidemiological studies
    530. Ciliary neurotrophic factor stimulates muscle glucose uptake by a PI3-kinase–dependent pathway that is impaired with obesity
    531. Nigella sativa oil potentiates the effects of pioglitazone on long term alloxan-induced diabetic rats
    532. Ecology then and Now
    533. Thiazolidinedione therapy in a patient with diabetes after cardiac transplantation
    534. Soybean and processed soy foods ingredients, and their role in cardiometabolic risk prevention
    535. Role of Leucine in Modulation of Mitochondrial Biogenesis and SIRT1-AMPK Signaling in C2C12 Myotubes
    536. Plasma phospholipids n‐3 polyunsaturated fatty acid is associated with metabolic syndrome
    537. Endocrine and Metabolic Dysfunction during Aging and Senescence: MyD88 regulates physical inactivity-induced skeletal muscle inflammation, ceramide …
    538. insulin resistance and progression of heart failure in the older adult
    539. N-3 polyunsaturated fatty acids and inflammation in obesity: local effect and systemic benefit
    540. Macrophage peroxisome proliferator activated receptor γ as a therapeutic target to combat type 2 diabetes
    541. Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
    542. Advanced proteomics procedure as a detection tool for predictive screening in type 2 pre-Diabetes
    543. Exercise-induced recovery of skeletal muscle insulin response is independent of adiponectin response in high-fat fed rodents
    544. Redox implications in adipose tissue (dys) function—a new look at old acquaintances
    545. Modulatory effects of diosgenin on attenuating the key enzymes activities of carbohydrate metabolism and glycogen content in streptozotocin-induced diabetic rats
    546. Role of MAP4K4 Signaling in Adipocyte and Macrophage Derived Inflammation: A Dissertation
    547. Freedom from Disease: The Breakthrough Approach to Preventing Cancer, Heart Disease, Alzheimer’s, and Depression by Controlling insulin
    548. Effects of age and acute submaximal exercise on inflammatory cytokines, cortisol, insulin, heat shock proteins and skeletal muscle mediators of energy homeostasis in …
    549. Metformin and metabolic diseases: a focus on hepatic aspects
    550. The role of PtdIns (4, 5) P2 and its regulatory proteins in the development of insulin resistance in cell culture models
    551. Pharmacological and Pharmaceutical Developments on Fagopyrum Tataricum
    552. THE HEPATITIS CVirus AND DIABETES MELLITUS ASSOCIATION: CHARACTERIZATION AND STUDIES OF RISK FACTORS, MECHANISMS, IMPLICATIONS AND …
    553. PMI 5011 regulates the ubiquitin proteasome system in skeletal muscle
    554. A cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin‐targeted keratinocyte grafts
    555. The effects of potassium ions and denervation on protein synthesis and the transport of amino acids in muscle
    556. The role of WNT10B in physiology and disease
    557. Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin
    558. Regulation of carbohydrate metabolism by the farnesoid X receptor
    559. Vascular endothelial growth factors: multitasking functionality in metabolism, health and disease
    560. Effects of transplantation and resection of a radiation-induced rat insulinoma on glucose homeostasis and the endocrine pancreas
    561. Endoplasmic reticulum stress and Nox-mediated reactive oxygen species signaling in the peripheral vasculature: potential role in hypertension
    562. Status of association studies linking diabetes mellitus and periodontal disease in India
    563. Critical Role of the Src Homology 2 (SH2) Domain of Neuronal SH2B1 in the Regulation of Body Weight and Glucose Homeostasis…
    564. The effect of a soy protein diet on attenuation of obesity-related pathologies in obese Zucker rats.
    565. Phosphorylation of insulin receptor substrate-1 in development of muscle insulin resistance
    566. What causes equine laminitis
    567. Pharmaceutical salts and cocrystals involving amino acids: a brief structural overview of the state-of-art
    568. Nuclear receptors: novel therapeutic targets for the treatment and prevention of atherosclerosis
    569. IKKβ and the anti-adipogenic effect of platelet-derived growth factor in human abdominal subcutaneous preadipocytes
    570. The role of sterol 12α-hydroxylase (Cyp8b1) in glucose homeostasis
    571. Suppression of nuclear factor-κB and stimulation of inhibitor κB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the …
    572. Repetitive DNA elements as mediators of genomic change in response to environmental cues
    573. Stop Inflammation Now!
    574. Chemical modulators working at pharmacological interface of target proteins
    575. Palmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity
    576. Biocatalysis: Synthesis of key intermediates for development of pharmaceuticals
    577. Hepatic organic anion transporting polypeptide transporter and thyroid hormone receptor interplay determines cholesterol and glucose homeostasis
    578. Maassen3, A. Edo Meinders1
    579. Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside
    580. Regulation of semicarbazide-sensitive amine oxidase expression by tumor necrosis factor-α in adipocytes: Functional consequences on glucose transport
    581. Hyperinsulinemia Tends to Induce Growth Without Growth Hormone in Children with Brain Tumors After Neurosurgery
    582. Effect of scaling and root planing on serum interleukin-10 levels and glycemic control in chronic periodontitis and type 2 diabetes mellitus
    583. Ginkgolide C suppresses adipogenesis in 3T3-L1 adipocytes via the AMPK signaling pathway
    584. Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment
    585. Angiotensin II receptors and drug discovery in cardiovascular disease
    586. Effect of weight-reduction in obese mice lacking toll-like receptor 5 and C57BL/6 mice fed a low-fat diet
    587. Clinical Pharmacology of Sulfonylureas
    588. CŞ BASICS
    589. Strengthening innate immunological weaponry against carcinogenesis
    590. Overnutrition, mTOR signaling, and cardiovascular diseases
    591. Heat Shock Proteins: Treating Metabolic Disease by Turning up the Heat
    592. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells
    593. Robust control in biology: From genes to cells to systems
    594. Factors affecting insulin-stimulated in vitro glucose oxidation in rat epididymal adipocytes
    595. The Endoplasmic reticulum and insulin signalling in adipocytes
    596. Diabetes: 8 strategies to put into practice
    597. Sleep apnea syndrome: implications on cardiovascular diseases
    598. Synthesis and characterization of insulin receptor partial agonists as a route to improved diabetes therapy
    599. c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges
    600. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat
    601. New treatments for chronic hepatitis C
    602. Identification of Biomarkers for Beta Cell Failure as Detection Tools for Predictive Screening in Type 2 Pre-diabetes
    603. Consequences of chronic inflammation in peritoneal dialysis
    604. Identification of a novel AS160 splice variant that regulates GLUT4 translocation and glucose-uptake in rat muscle cells
    605. Screening in Type 2 Pre-diabetes
    606. The Mechanisms Underlying Free Fatty Acid-induced Hepatic insulin Resistance
    607. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner
    608. Covalent peroxisome proliferator-activated receptorγ binding by nitro-fatty acids: Endogenous ligands act as selective modulators
    609. Review Article Different Adipose Depots: Their Role in the Development of Metabolic Syndrome and Mitochondrial Response to Hypolipidemic Agents.
    610. Diabetes and Its Association With Periodontal Tissues
    611. Development and validation of a high-precision capillary electrophoresis method for main component assay of ragaglitazar
    612. Polycystic Ovary Syndrome, Obesity and insulin Resistance
    613. JNK pathway signaling: a novel and smarter therapeutic targets for various biological diseases
    614. Hepatic effects of a fructose diet in the stroke-prone spontaneously hypertensive rat
    615. Beta-adrenoreceptor modulation of metabolic, endocrine and immunologic function during critical illness
    616. Coffee and type 2 diabetes risk
    617. Network analysis: a new approach to study endocrine disorders
    618. Metabolic and physiological studies in a rat model of type 2 diabetes
    619. Protective effects of SP600125 in a diet-induced rat model of non-alcoholic steatohepatitis
    620. Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor α/γ agonist ragaglitazar
    621. Feeding high oleic acid Canola oil or olive oil alters inflammation, insulin resistance and lipid metabolism in a rodent model of diet induced obesity
    622. Obesity-associated interleukin-6 contributes to hepatic insulin resistance in mice
    623. Role of PKB/Akt in liver diseases
    624. The race for interferon‐free HCV therapies: a snapshot by the spring of 2012
    625. Metformin inhibits the growth of nasopharyngeal carcinoma cells and sensitizes the cells to radiation via inhibition of the DNA damage repair pathway
    626. Mouse Models to Study Metformin Effects in Carcinogenesis
    627. Lack of Angiopoietin‐Like‐2 Expression Limits the Metabolic Stress Induced by a High‐Fat Diet and Maintains Endothelial Function in Mice
    628. Molecular Mechanisms Involved in Inflammation and insulin Resistance in Chronic Diseases and Possible Interventions
    629. Glycerolipid metabolism and signaling in health and disease
    630. Adaptive enzyme responses in adipose tissue of obese hyperglycemic mice
    631. Transcriptional regulation of adipose insulin resistance
    632. The role of adiponectin and the adipocyte in energy metabolism and inflammation
    633. Development of thiadiazole as an antidiabetic agent-a review
    634. Caenorhabditis elegans, an invertebrate model organism for biomedical research
    635. Adipokines and redox signaling: impact on fatty liver disease
    636. The liver in metabolic syndrome
    637. Management of diabetic ketoacidosis
    638. Correlative studies on the effects of obesity, diabetes and hypertension on gene expression in omental adipose tissue of obese women
    639. Imidazoline receptors in insulin signaling and metabolic regulation
    640. Caenorhabditiselegans, An Invertebrate Model Organism for Biomedical Research
    641. The effects of pharmacological management of depression on HbA1c in type 2 diabetes
    642. The polycystic ovary syndrome–challenges and opportunities in adolescent medicine
    643. Histone Deacetylase 8 Promotes insulin Resistance and β-catenin Activation in NAFLD-associated Hepatocellular Carcinoma
    644. Reduction of hepatic steatosis in rats and mice after treatment with a liver‐targeted thyroid hormone receptor agonist
    645. Cardiovascular mortality and morbidity in dialysis patients
    646. Citrus ichangensis peel extract exhibits anti-metabolic disorder effects by the inhibition of PPAR and LXR signaling in high-fat diet-induced C57BL/6 mouse
    647. Cardiovascular disease in renal transplant recipients
    648. FEDERICO II
    649. Antihepatotoxic activity of a quantified Desmodium adscendens decoction and D-pinitol against chemically-induced liver damage in rats
    650. ATP non-competitive Ser/Thr kinase inhibitors as potential anticancer agents
    651. The clinical role of hepatocyte and commensal-probiotic cell physiology in the successful detoxification of carcinogenic toxicants
    652. Endocrine aspects of pulmonary hypertension
    653. Studies on the mechanisms of action and physiological relevance of SOCS proteins
    654. 13 Olive Oil in Metabolic
    655. Managing diabetes and periodontal disease.
    656. Upstream molecular signaling pathways of p27 (Kip1) expression in human breast cancer cells in vitro: differential effects of 4-hydroxytamoxifen and …
    657. Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly
    658. The outliers become a stampede as immunometabolism reaches a tipping point
    659. Cardiovascular risk factors following renal transplant
    660. Belinda P. Childs, ARNP, MN, CDE, BC-ADM, is a diabetes nurse spe-cialist
    661. Collaboratively constructed contradictory accounts: online organizational narratives
    662. Protein–Protein Interactions: A Simple Strategy to Identify Binding Sites and Peptide Antagonists
    663. Does Mycobacterium avium subspecies paratuberculosis cause Crohn’s
    664. Metabolic hormones in bariatric surgery and reward behaviour
    665. STUDIES ON THE REGULATION OF FGF21 GENE EXPRESSION BY (R)-α-LIPOIC ACID: MECHANISTIC INSIGHT INTO THE LIPID LOWERING PROPERTIES OF A …
    666. Protein-protein interactions: network analysis and applications in drug discovery
    667. Outcomes of acute myocardial infarction in Type 2 diabetic Yemeni patients using different methods of treatment
    668. Non-systemic drugs: a critical review
    669. Mitochondrial energy failure in the eye induces loss of visual acuity in early metabolic syndrome: A novel therapeutic target
    670. Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and …
    671. Gene therapy technology applied to disorders of glucose metabolism: promise, achievements, and prospects
    672. Effect of nutrition education intervention and lifestyle behaviors on management of type 2 diabetes mellitus in Mwanza city, Tanzania
    673. Rheumatoid arthritis: an autoimmune disease with female preponderance and cardiovascular risk equivalent to diabetes mellitus: role of cardiovascular magnetic …
    674. Inhibitory Effect of Central Leptin on Hepatic Glucose Production in Streptozotocin (STZ)-Induced Diabetic Rats
    675. An association of boswellia, betaine and myo-inositol (Eumastós®) in the treatment of mammographic breast density: a randomized, double-blind study
    676. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48−/−Lepob/ob mice devoid of ApoE or Ldlr
    677. Therapeutical procedures to treat the metabolic syndrome in humans and animal models
    678. SCIENTIFIC SESSION ABSTRACTS
    679. Integrated characterization of cellular physiology underlying hepatic metabolism
    680. Metabolism and fatty acid profile in fat and lean rainbow trout lines fed with vegetable oil: effect of carbohydrates
    681. Cardiovascular Cells
    682. The Intricate Role of Adipokines in Immune-Mediated Diseases
    683. Endoplasmic reticulum stress is sufficient for the induction of IL-1β production via activation of the NF-κB and inflammasome pathways
    684. Feast or famine: Altered maternal nutrition and disease risk in offspring
    685. The Gut Microbiome–Clinical Implications for the Practicing Gastroenterologist
    686. The endothelial response to diabetes reveals a protective role for galectin-3 in diabetic vasculopathy and glucose metabolism
    687. Energy Balance and Cancer Risk: Metabolic and Molecular Studies
    688. Francesco Negro, Daniel Forton, 2 Antonio Craxì, 3 Mark S Sulkowski, 4 Jordan J. Feld, 5 Michael
    689. Discovery of peptides with balanced glucagon antagonism and GLP-1 agonism, supported by an investigation of their molecular basis for such action
    690. Curves: Permanent Results Without Permanent Dieting
    691. 15 Obesity and Type 2 Diabetes
    692. NON-PHARMACEUTICAL INTERVENTION OPTIONS FOR TYPE 2 DIABETES
    693. The Endocrine System
    694. dLipin- A Link Between Lipid Metabolism, Glucose Homeostasis and Growth in Drosophila melanogaster
    695. Role of the adipocyte in metabolism and endocrine function
    696. Chronic prenatal ethanol exposure produces neurobehavioural and metabolic dysfunction in guinea pig offspring
    697. Skeletal and Cardiac Muscle Energy Metabolism in Health and Disease
    698. 9 Mineral Deficiencies
    699. Mechanisms of Beta Cell Dysfunction and Application of Glp-1 Mimetics in Feline Diabetes Mellitus
    700. Regulation of the Mechanistic Target of Rapamycin by Cellular Stress.
    701. Negative regulation of the inflammasome: keeping inflammation under control
    702. Targeting mitochondrial function in diabetic nephropathy
    703. Developing C. elegans as a model to study Type 2 Diabetes Mellitus
    704. In Vivo Screening for Secreted Proteins That Modulate Glucose Handling Identifies Interleukin-6 Family Members as Potent Hypoglycemic Agents
    705. Terminal Modulator Protein (CTMP) regulates mitochondrial dynamics. PLoS One 4, e5471. Parone, PA, Da Cruz, S., Tondera, D., Mattenberger, Y., James, DI …
    706. First National Congress on Nutritional Medicine of the Dutch Nutraceutical Association
    707. The effect of conjugated linoleic acid (CLA) on sow and litter immune status and performance
    708. Proposed mechanisms underlining the potential effects of Staphylococcal superantigens on the development of type two diabetes
    709. Is there an embryopathy associated with first‐trimester exposure to angiotensin‐converting enzyme inhibitors and angiotensin receptor antagonists? A critical review …
    710. The Regulation of Net Hepatic Glucose Uptake in vivo
    711. STUDIES ON THE MECHANISMS OF ACTION AND PHYSIOLOGICAL RELEVANCE OF SOCS PROTEINS
    712. Achieving control of diabetic risk factors in primary care settings
    713. Hunger Free Forever: The New Science of Appetite Control
    714. Sweeteners and metabolic disorders
    715. Molecular aspects of alcohol metabolism: transcription factors involved in early ethanol-induced liver injury
    716. Jaypee Gold Standard Mini Atlas Series®: Diabetes
    717. TCF7L2 overexpression and type 2 diabetes: Dissecting the function of TCF7L2 as a regulator of glucose metabolism
    718. Multi-level regulation of argininosuccinate synthase: Significance for endothelial nitric oxide production
    719. Islet antibodies, autoimmunity, and β-cell function
    720. Continuous positive airway pressure therapy for sleep disordered breathing in adults
    721. GLP-1 CellBead Therapy for the Prevention of Left Ventricular Dysfunction in Pigs
    722. Promoting and maintaining physical activity in people with type 2 diabetes
    723. The Metabolic Syndrome and associated components among African women
    724. insulinoma
    725. Oxidative stress and inflammation as therapeutic targets of high-fat diet-induced metabolic diseases
    726. Cardiopulmonary and Quality of Life Responses of Individuals with Type 2 Diabetes to Therapeutic Excercises
    727. AMP-activated protein kinase, Sirtuin 1, and p53 interactions in HEPG2 cells
    728. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35
    729. The roles of ATF3 in stress-regulated signal transduction and cell death in pancreatic beta-cells
    730. The Role of the Cannabinoid Receptor Type 1 in Energy Balance, Glucose Metabolism, and Thermogenesis
    731. Phytanic acid alpha-oxidation, new insights into an old problem: a review
    732. Identification of bioactive compounds in wheat
    733. Diabetic macular oedema: the role of steroids and VEGF
    734. The Implications of CD36 Alteration on Rodent Skeletal Muscle Lipid Metabolism
    735. Adipose-derived Signals Induce Hyperplasia of the Mammary Epithelium in Response to 10e12z Conjugated Linoleic Acid Initiated Adipose Dysfunction
    736. Roles of ABCG5 ABCG8 cholesterol transporter in lipid homeostasis
    737. MEDICINE, SÃO PAULO, BRAZIL, OCTOBER 8–12, 2014
    738. Metabolic aspects of obesity
    739. Forkhead at the Crossroads of Cancer and Healthy Lifespan
    740. Metabolic Acidosis of Chronic Kidney Disease
    741. The Coconut Diet: The Secret Ingredient that Helps You Lose Weight While You Eat Your Favorite Foods
    742. Skeletal muscle fat infiltration is reversed by dietary fish oil in an animal model of colorectal cancer receiving irinotecan and 5-fluorouracil
    743. Dialed in
    744. Effects of chronic hyperglycemia on gene expression in streptozotocin-induced diabetic rats
    745. CHROMIUM SUPPLEMENTATION IN MANAGEMENT OF TYPE 2 DIABETES AMONG PATIENTS ATTENDING THIKA LEVEL 5 HOSPITAL, KENYA: A …
    746. Regulation of adipocyte and osteoblast differentiation by Wnt signaling
    747. Knowledge, opinions and practice behaviors of North Carolina endocrinologists’ and internists’ regarding periodontal disease and diabetes
    748. Unraveling the molecular physiology of the β-cell: genome wide analysis of binding sites for the transcription factor PDX1
    749. Cerebral blood flow and glucose metabolism in ischemic stroke: multimodal imaging investigations in a clinically relevant rat model
    750. Health promoting factors from milk of cows fed green plant material-The role of phytanic acid
    751. Fatty liver syndrome in mink-causes and metabolic consequences
    752. 4 Caloric Intake: Sources, Deficiencies
    753. List of Abstracts
    754. Effect of dietary polyunsaturated fatty acids on rat tissue oxylipin profiles
    755. Multi-modal Analysis of Metabolic Enzyme Disruption in Adipocytes
    756. The Design, Characterization, and Efficacy of Protease-Resistant Therapeutic Peptides
    757. MEDICAL LIBRARY
    758. Discovery and Characterization of Inflammation-Induced Electrophilic Fatty Acid Derivatives
    759. Becoming Vegan: The Complete Reference to Plant-Base Nutrition
    760. 12 CE in impurity profiling of drugs
    761. An Investigation of the Relationship Between Dermal Stresses and Foot Ground Stresses in Diabetic Patients
    762. Inhibition of Class I HDACs Blunts Cardiac Hypertrophy via TSC2-Dependent mTOR Repression
    763. In vitro screening assay using the murine pre-adipocyte cell line 3T3-L1 to study anti-obesogenic activities of cyanobacterial compounds
    764. HEALTH SEEKING BEHAVIOUR AND PATTERN OF ADHERENCE TO TREATMENT AMONG PATIENTS WITH TYPE-2 DIABETES MELLITUS IN CENTRAL …
    765. Effects of vitamin A deficiency on retinoid and energy metabolism in liver and white adipose tissue
    766. CD64-mediated specific elimination of M1-polarized macrophages: implications for therapeutic intervention in chronic inflammatory diseases
    767. Recent Advances in Stem Cell Research
    768. Design and Synthesis of Functionalized Mn (III) Dipyrromethene Complexes as Peroxynitrite Decomposition Catalysts
    769. Thrive with diabetes
    770. The in vitro and in vivo anti-oxidative and anti-diabetic effects of some African medicinal plants and the identification of the bioactive compounds.
    771. Health seeking and health related behaviour for type 2 diabetes mellitus among adults in an urban community in Tanzania
    772. Manipulating Protein Stability with Small Molecules: Applications in studying biological systems and accessing new drug targets
    773. Message from Chief Guest
    774. Role of Endoplasmic Reticulum Stress Response Signaling in T Cells: A Dissertation
    775. Physiological Consequences of Compartmentalized Glycerolipid Synthesis
    776. Cost-effectiveness of disease interventions in India
    777. Putting ‘sugar diabetes’ on the table: Evaluating “The Sugar Plays” as entertainment-education in Appalachia
    778. Community Based Interactive Approach for Type 2 Diabetic Patients at Addaraja Health Center, Wad Medani, Sudan
    779. Emotional Vampires and Your Hormones: An Holistic Physician’s View on How Stress Affects Your Well-Being and What You Can Do About It
    780. The Role and Regulation of Sox9 in the Human Hair Follicle and Basal Cell Carcinoma
    781. A bittersweet existence: the lived experiences of four young women with diabetes mellitus
    782. Acid-base balance and oxidative metabolism in calcified tissues
    783. Investigation Into the Role of ER Stress in the Pathology of Metaphyseal Chondrodysplasia Type Schmid
    784. WNT SIGNALLING IN NORMAL DEVELOPMENT AND CANCER PROGRESSION
    785. … and insulin resistance: New targets encourage new thinking: Galectin‐3 and LTB4 are pro‐inflammatory molecules that can be targeted to restore insulin sensitivity
    786. Discovery of Highly Selective Inhibitors of Calmodulin-Dependent Kinases That Restore insulin sensitivity in the Diet-Induced Obesity in Vivo Mouse Model
    787. Interleukin-4 restores insulin sensitivity in lipid-induced insulin-resistant adipocytes
    788. Two nights of recovery sleep restores the dynamic lipemic response, but not the reduction of insulin sensitivity, induced by five nights of sleep restriction
    789. Cutting calories and TXNIP from the skeletal muscle to restore insulin sensitivity
    790. Gal3 links inflammation and insulin resistance
    791. Avocatin B Protects Against Lipotoxicity and Improves insulin sensitivity in Diet‐Induced Obesity
    792. A novel recombinant peptide INSR-IgG4Fc (Yiminsu) restores insulin sensitivity in experimental insulin resistance models
    793. Suppression of GATA-3 increases adipogenesis, reduces inflammation and improves insulin sensitivity in 3T3L-1 preadipocytes
    794. Chaperone-based therapeutic target innovation: Heat shock protein 70 (HSP70) for Type 2 diabetes mellitus
    795. Decreased acylcarnitine content improves insulin sensitivity in experimental mice models of insulin resistance
    796. Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2
    797. Cardiovascular and Metabolic Consequences of Sleep and/or Circadian Disruption: Two nights of recovery sleep restores the dynamic lipemic response, but …
    798. Mitochondria and endoplasmic reticulum: Targets for a better insulin sensitivity in skeletal muscle?
    799. Developmental programming: impact of gestational steroid and metabolic milieus on mediators of insulin sensitivity in prenatal testosterone–treated female sheep
    800. Long-term rates of mitochondrial protein synthesis are increased in mouse skeletal muscle with high-fat feeding regardless of insulin-sensitizing treatment
    801. Adipocyte JAK2 regulates hepatic insulin sensitivity independently of body composition, liver lipid content, and hepatic insulin signaling
    802. Tumour necrosis factor α induces neuroinflammation and insulin resistance in immortalised hypothalamic neurones through independent pathways
    803. Impact of sleep deprivation and high-fat feeding on insulin sensitivity and beta cell function in dogs
    804. Functional abolition of carotid body activity restores insulin action and glucose homeostasis in rats: key roles for visceral adipose tissue and the liver
    805. Targeting insulin resistance with selected antidiabetic agents prevents menopausal associated central obesity, dysglycemia, and cardiometabolic risk
    806. Neuraminidase 1 activates insulin receptor and reverses insulin resistance in obese mice
    807. Obesity-associated alterations in glucose metabolism are reversed by chronic bilateral stimulation of the abdominal vagus nerve
    808. The manifold role of the mitochondria in skeletal muscle insulin resistance
    809. S-Nitrosoglutathione Reverts Dietary Sucrose-Induced insulin Resistance
    810. High frequency shift in Carotid Sinus Nerve and Sympathetic Nerve activity in Type 2 Diabetic Rat Model*
    811. Nutrient restriction increases circulating and hepatic ceramide in dairy cows displaying impaired insulin tolerance
    812. Obesity in menopause–our negligence or an unfortunate inevitability?
    813. Effect of aging on current flow due to transcranial direct current stimulation
    814. TXNIP in metabolic regulation: physiological role and therapeutic outlook
    815. Increased insulin sensitivity by High-Altitude Hypoxia in Mice with High-Fat Diet-Induced Obesity Is Associated with Activated AMPK Signaling and Subsequently …
    816. Glutamine metabolism regulates autophagy-dependent mTORC1 reactivation during amino acid starvation
    817. Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance
    818. Reactive oxygen species enhance mitochondrial function, insulin sensitivity and glucose uptake in skeletal muscle of senescence accelerated prone mice SAMP8
    819. Effects of a ruthenium schiff base complex on glucose homeostasis in diet-induced pre-diabetic rats
    820. The transcription factor Prep1 controls hepatic insulin sensitivity and gluconeogenesis by targeting nuclear localization of FOXO1
    821. Protocatechuic acid exhibits hepatoprotective, vasculoprotective, antioxidant and insulin-like effects in dexamethasone-induced insulin-resistant rats
    822. Interleukin-4 Restores insulin sensitivity in insulin-Resistant Osteoblasts by Increasing the Expression of insulin Receptor Substrate 1
    823. Plant Bioactives and the Intestinal Barrier: Redox Signaling and Implications for insulin Resistance
    824. Regulation of insulin sensitivity by Skeletal Muscle Specific Modulation Of p21‐Activated Kinase 1 (PAK1)
    825. Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates
    826. MicroRNA miR-222 mediates pioglitazone beneficial effects on skeletal muscle of diet-induced obese mice
    827. Oridonin prevents insulin resistance–mediated cognitive disorder through PTEN/Akt pathway and autophagy in minimal hepatic encephalopathy
    828. Endoplasmic reticulum stress causes insulin resistance by inhibiting delivery of newly synthesized insulin receptors to the cell surface
    829. A hypothesis for insulin resistance in primary human adipocytes involving MRTF-A and suppression of PPARγ
    830. Cefdinir microsphere modulated microflora and liver immunological response to diet induced diabetes in mice
    831. Effect of single anastomosis duodenal-ileal bypass with sleeve gastrectomy on glucose tolerance test: comparison with other bariatric procedures
    832. Exercise and polycystic ovary syndrome
    833. Hematopoietic Cell–Expressed Endothelial Nitric Oxide Protects the Liver From insulin Resistance
    834. insulin resistance and Parkinson’s disease: a new target for disease modification?
    835. Arginase inhibition prevents the development of hypertension and improves insulin resistance in obese rats
    836. Protective role of osteocalcin in diabetes pathogenesis
    837. Serum Level of Galectin-3 and Its Relation to insulin Resistance in Patients with Androgenetic Alopecia
    838. Effect of thiazolidinediones on adipocytokines and lipid profile in insulin resistant sprague dawley rats
    839. Transcranial direct current stimulation (tDCS) improves cognitive-motor performance in older adults with cerebral microvascular disease
    840. IL-17A contributes to propagation of inflammation but does not impair adipogenesis and/or insulin response, in adipose tissue of obese individuals
    841. Mitochondrial (Dys) function and insulin resistance: from pathophysiological molecular mechanisms to the impact of diet
    842. THE EFFECTS OF SLEEP RESTRICTION AND SUBSEQUENT SLEEP RECOVERY ON GLYCEMIC AND LIPEMIC METABOLISM.
    843. Anthocyanin Improves Glucose Homeostasis in Obese Mice via Regulation of Intestinal Microbiota and Barrier Function
    844. Could vagus nerve stimulation have a role in the treatment of diabetes?
    845. Mitochondria Dysfunction in Aging and Metabolic Diseases: Long-term rates of mitochondrial protein synthesis are increased in mouse skeletal muscle with …
    846. Impact of exercise on glucose homeostasis in different mouse models for impaired insulin sensitivity
    847. The metabolic stress response to burn trauma: current understanding and therapies
    848. 2-Arachidonoylglycerol ameliorates inflammatory stress-induced insulin resistance in cardiomyocytes
    849. insulin Resistance and T1D: The Effect of Exercise on Skeletal Muscle Lipid Metabolism
    850. SGLT inhibitors for type 1 diabetes: an obvious choice or too good to be true?
    851. The Effects of Western-diet, Palmitate, and TNFα on Hypothalamic Circadian Rhythms, NPY Expression, Neuroinflammation, and Cellular insulin sensitivity
    852. The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight …
    853. 9-Therapeutic Targeting of Skeletal Muscle Nix in Early-Onset insulin Resistance
    854. Regulation of skeletal muscle insulin sensitivity by PAK1
    855. Coordinated transcriptional control of adipocyte triglyceride lipase (Atgl) by transcription factors Sp1 and peroxisome proliferator–activated receptor γ (PPARγ) …
    856. The in Silico Study of Nutmeg Seeds (Myristica fragrans Houtt) as Peroxisome Proliferator Activated Receptor Gamma Activator Using 3D-QSAR …
    857. Modulation of visfatin levels by thiazolidinediones in insulin resistant sprague dawley rats
    858. Synergistic Effect of Two Major Components of Malva verticillata in the Recovery of Alloxan-Damaged Pancreatic Islet Cells in Zebrafish
    859. TNF-α as an Adipokine
    860. Anti-diabetic effects of excipients: possibility of formulation of an anti-diabetic dosage form using pharmaceutical excipients or their constituents, or food …
    861. 12-Examining the Role of the HNF-1a G319S Variant in Liver Function and Early-Onset Type 2 Diabetes
    862. 11-Investigating the Roles of Transcription Factor EB (TFEB) in β-Cell Function and Survival Under Stress
    863. Treatment of insulin resistance: straight from the gut
    864. Revisiting Caloric Restriction as Therapeutic Strategy for Metabolic Syndrome, T2DM and Obesity
    865. Reducing the burden of obesity-associated cancers with anti-inflammatory long-chain omega-3 polyunsaturated fatty acids
    866. Ad libitum weekend recovery sleep fails to prevent metabolic dysregulation during a repeating pattern of insufficient sleep and weekend recovery sleep
    867. Mechanisms of macrophage polarization in insulin signaling and insulin sensitivity
    868. Why We Age: From Healthy Aging
    869. PPARγ in complex with an antagonist and inverse agonist: a tumble and trap mechanism of the activation helix
    870. IRS posttranslational modifications in regulating insulin signaling
    871. Adiponectin and aldosterone in left ventricular hypertrophy: an intriguing interplay
    872. Overview of ketone-based metabolism
    873. UNRAVELING THE LINK BETWEEN CAROTID BODY, insulin AND DOPAMINE.
    874. Role of Omega-3 Fatty Acids in Metabolic Syndrome
    875. Correction of metabolic acidosis improves insulin resistance in chronic kidney disease
    876. Antidiabetic effect of casein glycomacropeptide hydrolysates on high-fat diet and STZ-induced diabetic mice via regulating insulin signaling in skeletal muscle and …
    877. Developmental programming: insulin sensitizer prevents the GnRH-stimulated LH hypersecretion in a sheep model of PCOS
    878. Poly (I: C) alleviates obesity related pro-inflammatory status and promotes glucose homeostasis
    879. The Effects of Estrogen, Grape Pomace, and Resveratrol Supplementation on Glucose Tolerance and insulin Signaling in Ovariectomized Rats.
    880. Casein glycomacropeptide hydrolysates ameliorate hepatic insulin resistance of C57BL/6J mice challenged with high-fat diet
    881. Knockdown of PTRF ameliorates adipocyte differentiation and functionality of human mesenchymal stem cells
    882. AMPK activation by metformin suppresses abnormal extracellular matrix remodeling in adipose tissue and ameliorates insulin resistance in obesity
    883. Markedly improved glycemic control in poorly controlled type 2 diabetes following direct acting antiviral treatment of genotype 1 hepatitis C
    884. Fructose induced neurogenic hypertension mediated by overactivation of p38 MAPK to impair insulin signaling transduction caused central insulin resistance
    885. Characterizing the Mechanisms of insulin Resistance in Dairy Cattle
    886. Preventive effect of oleate on palmitate-induced insulin resistance in skeletal muscle and its mechanism of action
    887. Vitamin D deficiency causes insulin resistance by provoking oxidative stress in hepatocytes
    888. CCL5/RANTES contributes to hypothalamic insulin signaling for systemic insulin responsiveness through CCR5
    889. Rosiglitazone improves insulin resistance mediated by 10, 12 conjugated linoleic acid in a male mouse model of metabolic syndrome
    890. insulin resistance elicited in postpubertal primate offspring deprived of estrogen in utero
    891. Houttuynia cordata facilitates metformin on ameliorating insulin resistance associated with gut microbiota alteration in OLETF rats
    892. Class effect for SGLT-2 inhibitors: a tale of 9 drugs
    893. Paeoniflorin suppresses lipid accumulation and alleviates insulin resistance by regulating the Rho kinase/IRS-1 pathway in palmitate-induced HepG2Cells
    894. Vitamin D deficiency enhances insulin resistance by promoting inflammation in type 2 diabetes
    895. Soluble CD14 inhibits contractile function and insulin action in primary adult rat cardiomyocytes
    896. Cyanidin-3-O-glucoside restores insulin signaling and reduces inflammation in hypertrophic adipocytes
    897. Role of probiotics in diabetes: a review of their rationale and efficacy
    898. Uncovering the Complex Metabolic Role of Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT)
    899. Antidiabetic and Cardioprotective Effects of Pharmacological Inhibition of GRK2 in db/db Mice
    900. Metabolomic response of skeletal muscle to aerobic exercise training in insulin resistant type 1 diabetic rats
    901. TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl) purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway
    902. Long-term hypercaloric diet consumption exacerbates age-induced metabolic dysfunction: Beneficial effects of CSN denervation
    903. The effect of electric field, magnetic field, and infrared ray combination to reduce HOMA-IR index and GLUT 4 in diabetic model of Mus musculus
    904. Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study
    905. Decreased RNF41 expression leads to insulin resistance in skeletal muscle of obese women
    906. Polyphenol‐rich virgin olive oil reduces insulin resistance and liver inflammation and improves mitochondrial dysfunction in high‐fat diet fed rats
    907. Targeting inflammation and downstream protein metabolism in sarcopenia: a brief up-dated description of concurrent exercise and leucine-based multimodal …
    908. Oleuropein ameliorates palmitate-induced insulin resistance by increasing Glut4 translocation through activation of AMPK
    909. Pharmacological targeting of the unfolded protein response for disease intervention
    910. Effect of ionic liquid components on the coil dimensions of PEO
    911. The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease
    912. Purple sweet potato color improves hippocampal insulin resistance via down-regulating SOCS3 and galectin-3 in high-fat diet mice
    913. Heat therapy improves glucose tolerance and adipose tissue insulin signaling in polycystic ovary syndrome
    914. Redox-Responsive Dipeptide Nanostructures toward Targeted Cancer Therapy
    915. Idebenone is a cytoprotective insulin sensitizer whose mechanism is Shc inhibition
    916. Inhibition of mitochondrial fission and iNOS in the dorsal vagal complex protects from overeating and weight gain
    917. Role of pro-and anti-inflammatory phenomena in the physiopathology of type 2 diabetes and obesity
    918. C-Phycocyanin inhibits hepatic gluconeogenesis and increases glycogen synthesis via activating Akt and AMPK in insulin resistance hepatocytes
    919. Mesoporous TiO2 Support Materials for Ru-Based CO2 Methanation Catalysts
    920. Developmental programming of PCOS traits: insights from the sheep
    921. The Potential Anti-Diabetic Effects of Some Plant Species
    922. Pharmacological Targeting of IRE1α Ameliorates insulin Resistance Through Preservation of the insulin Receptor Signaling Pathway
    923. Protocatechuic acid improves hepatic insulin resistance and restores vascular oxidative status in type-2 diabetic rats
    924. Starvation, carbohydrate loading, and outcome after major surgery
    925. Current trends in small molecule discovery targeting key cellular signaling events towards the combined management of diabetes and obesity
    926. Metformin in the treatment of adults with type 2 diabetes mellitus
    927. Ab Initio Study of CO2 Capture Mechanisms in Aqueous 2-Amino-2-methyl-1-propanol: Electronic and Steric Effects of Methyl Substituents on the Stability of …
    928. Coordinated regulation of miR-27 by insulin/CREB/Hippo contributes to insulin resistance
    929. Adiponectin is required for pioglitazone-induced improvements in hepatic steatosis in mice fed a high-fat diet
    930. Exercise and insulin resistance in PCOS: muscle insulin signalling and fibrosis
    931. The role of dietary fat in obesity-induced insulin resistance
    932. Disturbances in insulin–Glucose Metabolism in Patients With Advanced Renal Disease With and Without Diabetes
    933. Manipulation of the growth hormone-insulin-like growth factor (GH-IGF) axis: A treatment strategy to reverse the effects of early life developmental programming
    934. The Effect of Bean Juice for Reduction Blood Glucose Levels in Psychological Stress
    935. Osteocalcin prevents insulin resistance, hepatic inflammation, and activates autophagy associated with high-fat diet–induced fatty liver hemorrhagic syndrome …
    936. Anti-inflammatory effect of piperine ameliorates insulin resistance in monosodium glutamate–treated obese mice
    937. Niclosamide as an anti-obesity drug: an experimental study
    938. Th17 and Treg lymphocytes in obesity and Type 2 diabetic patients
    939. Bortezomib attenuates palmitic acid-induced ER stress, inflammation and insulin resistance in myotubes via AMPK dependent mechanism
    940. Silibinin attenuates adipose tissue inflammation and reverses obesity and its complications in diet-induced obesity model in mice
    941. Effect of metformin monotherapy on serum lipid profile in statin-naïve individuals with newly diagnosed type 2 diabetes mellitus: a cohort study
    942. insulin signalling in hypothalamic neurones
    943. PPARG post-translational modifications regulate bone formation and bone resorption
    944. Regulation of hepatic glucose metabolism in health and disease
    945. Mechanisms of insulin action and insulin resistance
    946. Relationship between metabolic disorders and breast cancer incidence and outcomes. Is there a preventive and therapeutic role for berberine?
    947. Neratinib protects pancreatic beta cells in diabetes
    948. IP6K1 reduces mesenchymal stem/stromal cell fitness and potentiates high fat diet‐induced skeletal involution
    949. Nigella sativa L. oil ameliorates insulin resistance caused by dexamethasone treatment in male Wistar rats
    950. Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders
    951. Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR) α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin …
    952. Quantitative in vivo proteomics of metformin response in liver reveals AMPK-dependent and-independent signaling networks
    953. Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell
    954. Adipocytes properties and crosstalk with immune system in obesity‐related inflammation
    955. Cinnamon extract combined with high-intensity endurance training alleviates metabolic syndrome via non-canonical WNT signaling
    956. Metformin reverses established lung fibrosis in a bleomycin model
    957. Towards resolving the enigma of the dichotomy of resveratrol: cis-and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activation
    958. Elevated Carbohydrate Response Element-Binding Protein Beta (ChREBPβ) and Thioredoxin Interacting Protein (TXNIP) Levels in Human Adipocytes Differentiated …
    959. insulin activates hepatic Wnt/β-catenin signaling through stearoyl-CoA desaturase 1 and Porcupine
    960. Mesenchymal stem cell therapy in type 2 diabetes mellitus
    961. NHX-5, an endosomal Na+/H+ exchanger, is associated with metformin action
    962. Effects of zingiber officinale extract supplementation on metabolic and genotoxic parameters in diet-induced obesity in mice
    963. Effect of long-term growth hormone replacement on glucose metabolism in adults with growth hormone deficiency: a systematic review and meta-analysis
    964. The actin-related p41ARC subunit contributes to p21-activated kinase-1 (PAK1)–mediated glucose uptake into skeletal muscle cells
    965. Role of gut microbiota in type 2 diabetes pathophysiology
    966. Rac1 and AMPK account for the majority of muscle glucose uptake stimulated by ex vivo contraction but not in vivo exercise
    967. Lower Blood Sugar Prevents Diabetes
    968. Role of hyperglycaemia in the relationship between serum osteocalcin levels and relative skeletal muscle index
    969. Role of the blood-brain barrier in central nervous system insulin resistance
    970. Promising inhibitory effects of anthraquinones, naphthopyrone, and naphthalene glycosides, from Cassia obtusifolia on α-glucosidase and human protein tyrosine …
    971. Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver
    972. Thyroid hormone analogs for the treatment of dyslipidemia: past, present, and future
    973. Alkaloids potential health Benefits and toxicity
    974. Innate lymphoid cells as novel regulators of obesity and its‐associated metabolic dysfunction
    975. Protein tyrosine phosphatase 1B (PTP1B): a potential target for Alzheimer’s therapy?
    976. Xenobiotic mediated diabetogenesis: Developmental exposure to dichlorvos or atrazine leads to type 1 or type 2 diabetes in Drosophila
    977. Closed-loop control systems–The quest for precision therapies for diabetes
    978. Potential Protective Effects of Neonatal Supplementation with Oleanolic Acid on Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)-Ligand Dependent …
    979. Bone-derived factors: a new gateway to regulate glycemia
    980. Angiotensin receptor subtypes regulate adipose tissue renewal and remodelling
    981. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials
    982. Evaluation of DEFB1 polymorphisms in individuals with chronic periodontitis and diabetes mellitus type 2 in a population of northeastern Brazil
    983. Possible effects of dietary anthocyanins on diabetes and insulin resistance
    984. New Era of Perio Systemic Interrelationship
    985. Anti-adiposity impact of phosphodiesterase-5 inhibitor, Sildenafil is possibly through browning of white adipose tissue and FGF21 in obese rats
    986. Developmental programming: gestational testosterone excess disrupts LH secretion in the female sheep fetus
    987. Glucose-lowering Strategies in Diabetes: Pharmacological Development of New Anti-diabetic Drugs
    988. Dietary 23-hydroxy ursolic acid protects against diet-induced weight gain and hyperglycemia by protecting monocytes and macrophages against nutrient stress …
    989. Influence on hydrate dissociation for methane hydrates formed in the presence of PolyVinylCaprolactam versus PolyVinylCaprolactam+ Butyl Glycol Ether
    990. Circulating adiponectin levels in type 2 diabetes mellitus patients with or without non-alcoholic fatty liver disease: Results of a small, open-label, randomized …
    991. Acute effects of active breaks during prolonged sitting on subcutaneous adipose tissue gene expression: an ancillary analysis of a randomised controlled trial
    992. Thyroid hormone analogues: An update
    993. Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin
    994. Increased mitochondrial calcium uniporter in adipocytes underlies mitochondrial alterations associated with insulin resistance
    995. The Effects of Solvent Polarity on Hypoglycemic and Hypolipidemic Activities of Vaccinium Arctostaphylos L. Unripe Fruits
    996. Inflammatory features of obesity and smoke exposure and the immunologic effects of exercise
    997. The apelin/APJ system as a therapeutic target in metabolic diseases
    998. For Management of Obesity and Diabetes: Is Timing the Answer?
    999. Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases
    1000. Biohydrogenation of linoleic acid by lactic acid bacteria for the production of functional cultured dairy products: A review
    1001. Resistin in metabolism, inflammation, and disease
    1002. Tailoring treatment for PCOS phenotypes
    1003. Growth hormone and insulin signaling in acromegaly: impact of surgery versus somatostatin analog treatment
    1004. DUSP5 Regulation of Inflammation and insulin Signaling
    1005. Bariatric and metabolic therapies targeting the small intestine
    1006. Essential roles for the non-canonical IκB kinases in linking inflammation to cancer, obesity, and diabetes
    1007. The effect of type 2 diabetes diagnosis in the elderly
    1008. Sexual function, obesity, and weight loss in men and women
    1009. The chronic effects of dietary (poly) phenols on mitochondrial dysfunction and glucose uptake in cellular models of the liver and skeletal muscle.
    1010. Does improved periodontal health affect metabolic and inflammatory markers in patients with diabetes mellitus? A comparative study
    1011. Nitric oxide exerts basal and insulin-dependent anorexigenic actions in POMC hypothalamic neurons
    1012. Resveratrol and quercetin administration improves antioxidant DEFENSES and reduces fatty liver in metabolic syndrome rats
    1013. Identification of putative biomarkers for type 2 diabetes using metabolomics in the Korea Association REsource (KARE) cohort
    1014. Downregulation of miR-181a alleviates renal fibrosis in diabetic nephropathy mice
    1015. Protective Effects and Mechanisms of Action of methyl-GBB in the Preclinical Models of Diabetes and Its Complications. Summary of the Doctoral Thesis
    1016. VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses
    1017. Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome
    1018. Comorbidities and nonalcoholic fatty liver disease: the chicken, the egg, or both?
    1019. Deletion of TXNIP mitigates high-fat diet-impaired angiogenesis and prevents inflammation in a mouse model of critical limb ischemia
    1020. Th